104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain

Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/18667

Title:	104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain
Authors:	Juan Pereyra-Rodriguez, Jose Dominguez-Cruz, Javier Carlos Armario-Hita, Jose Ruiz-Villaverde, Ricardo
metadata.dc.contributor.authoraffiliation:	[Juan Pereyra-Rodriguez, Jose] Hosp Univ Virgen Rocio, Dermatol Unit, Seville, Spain [Dominguez-Cruz, Javier] Hosp Univ Virgen Rocio, Dermatol Unit, Seville, Spain [Carlos Armario-Hita, Jose] Hosp Univ Puerto Real, Dermatol Unit, Cadiz, Spain [Ruiz-Villaverde, Ricardo] Hosp Univ San Cecilio, Dermatol Unit, Granada, Spain
Issue Date:	9-Nov-2021
Publisher:	Elsevier science inc
URI:	http://hdl.handle.net/10668/18667
metadata.dc.identifier.doi:	10.1016/j.abd.2020.08.030
ISSN:	0365-0596
Appears in Collections:	Producción 2020

Files in This Item:

There are no files associated with this item.

This item is protected by original copyright

Show full item record Recommend this item

This item is licensed under a Creative Commons License

RISalud